Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents
January 31st, 2020
We describe a method for preparation of the single freshly isolated detrusor smooth muscle cells from human urinary bladder specimens employing a two-step enzymatic procedure. The obtained viable DSM cells can be studied by various single cell techniques including the described amphotericin-B patch-clamp electrophysiology to reveal physiological and pharmacological properties.
Overview
This study presents a validated method for the isolation of single detrusor smooth muscle (DSM) cells from human urinary bladder specimens. The viability of these cells allows for detailed physiological and pharmacological investigations, including patch-clamp electrophysiology to study ion channels like TRPM4.
Key Study Components
Research Area
- Cell biology
- Electrophysiology
- Pharmacology
Background
- Detrusor smooth muscle cells are crucial for urine storage and voiding.
- Single cell studies can aid in understanding disease mechanisms and treatment targets.
- Electrophysiological analyses help validate pharmacological effects on ion channels.
Methods Used
- Enzymatic isolation of fresh DSM cells from human bladder tissue.
- Amphotericin-B patch-clamp electrophysiology to study ion channel functions.
- Observation of cell morphology and viability post-isolation.
Main Results
- Isolated DSM cells exhibited distinct morphological characteristics indicating viability.
- Experiments demonstrated that 9-phenanthrol effectively inhibits TRPM4-related currents in DSM cells.
- Key experimental conditions were critical for obtaining high-quality cells.
Conclusions
- The method allows for the study of ion channel pharmacology at a single cell level.
- Findings have implications for understanding bladder physiology and potential therapeutic approaches.
Frequently Asked Questions
Executive Industry Relevance
Freshly isolated human detrusor smooth muscle (DSM) cells enable direct interrogation of ion channel function and pharmacological target validation at the single-cell level. This capability is critical for de-risking early discovery hypotheses and establishing predictive confidence in bladder physiology research. The method supports translational continuity from target validation through preclinical model development in urological drug discovery portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional validation of ion channels such as TRPM4 in human DSM cells.
- Supports mechanistic de-risking by isolating single-cell responses to pharmacological agents.
- Facilitates direct assessment of disease-relevant cellular mechanisms in human tissue.
Screening & Assay Development
- Provides high-quality, viable DSM cells for reproducible patch-clamp and molecular assays.
- Enables quantitative measurement of cation currents and pharmacological inhibition profiles.
- Supports assay standardization and scalability for downstream compound evaluation.
Translational & Preclinical Research
- Aligns single-cell functional data with molecular profiling for biomarker discovery.
- Enables continuity from human tissue characterization to preclinical model validation.
- Reduces translational risk by anchoring findings in primary human cells.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from early target validation to preclinical research, providing a foundation for mechanistic studies and assay development.
- Discovery Biology: Supports hypothesis testing and pathway clarification for ion channel targets in DSM cells.
- Screening: Delivers reproducible, quantitative electrophysiological outputs for compound profiling.
- Analytics: Enables measurement of voltage-step evoked cation currents and pharmacological inhibition.
- Translational Research: Bridges human cellular data to preclinical model selection and biomarker alignment.
- Enterprise Reuse: Establishes a validated workflow for ongoing target and pathway interrogation in urological research.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes isolation and assay protocols for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in early-stage programs.
- Portfolio Impact: Enables risk-adjusted prioritization of ion channel targets and pharmacological strategies.
Implementation Considerations
- Requires expertise in human tissue dissection and enzymatic cell isolation.
- Demands access to patch-clamp instrumentation and analytical infrastructure.
- Necessitates cross-team standardization of cell quality and assay protocols.
- Adaptation may be needed for different tissue sources or disease states.
- Cell viability and enzyme treatment conditions are critical for reproducible outputs.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:45
Dissection and Enzymatic Dissociation of Mucosa-free DSM Pieces
3:28
Voltage-step Induced Cation Currents from DSM Cells Using Amphotericin-B Perforated Whole-cell Voltage Patch-clamp Technique
5:52
Results: Investigation of Ion Channel Properties in Isolated DSM Cells
7:07
Conclusion
